Neuroscience startup NeuroLeap raises funding from Rajashree Birla, Sminu Jindal
Photo Credit: Pixabay

NeuroLeap, a brain enhancement and mental health startup based in Mumbai, has raised funding from philanthropist Rajashree Birla and Jindal SAW Ltd managing director Sminu Jindal.

The startup said in a statement that the investments by Birla, the chairperson of the Aditya Birla Centre for community initiatives and rural development, and Jindal will help it grow its presence across the country. It didn’t disclose the amount of money it raised.

Company founder Kumaar Bagrodia said it has helped clients with various mental health disorders such as anxiety, clinical depression and insomnia lead healthier lives.

Jindal said she was confident in her investment because of NeuroLeap’s technological solutions successfully delivering better outcomes for mental health.

The company says it uses advanced brain computer interface-based technology to understand brain activity and help it perform at optimal potential. NeuroLeap claims it has helped people enhance brain function, improve sleep, and strengthen memory and emotional health.

Deals in the health-technology segment

Investment activity in the health-tech segment has been strong as startups seek to differentiate themselves by addressing gaps in traditional healthcare models as well as offering frontier technology-based solutions.

Last month, Meddo, a health-technology startup that integrates physical and online healthcare services, raised $3 million (about Rs 21.53 crore). Similarly, PlusPin Healthcare raised Rs 5.25 crore in its seed round of funding from a clutch of investors of the Indian Angel Network (IAN) including former Google India head Rajan Anandan.

In July, HealthAssure Pvt. Ltd, an online aggregator of primary healthcare services, secured $2.5 million from early-stage venture capital firm Blume Ventures in its Series A round of funding.

Also in July, Bengaluru-based mfine mobilised Rs 31 crore in debt funding from venture debt firm Alteria Capital. The company uses its artificial intelligence-powered platform to connect patients with doctors for virtual consultations.

Leave Your Comment(s)